Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on X/Twitter:
“Interesting read on many recent pharmacological advancements and deals in the ADC field. Exciting times ahead.”
Source: Paolo Tarantino/X